0002141184-26-000002.txt : 20260624 0002141184-26-000002.hdr.sgml : 20260624 20260624150637 ACCESSION NUMBER: 0002141184-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260624 DATE AS OF CHANGE: 20260624 EFFECTIVENESS DATE: 20260624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ollin Biosciences, Inc. CENTRAL INDEX KEY: 0002141184 ORGANIZATION NAME: EIN: 932578229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-588459 FILM NUMBER: 261115499 BUSINESS ADDRESS: STREET 1: 1250 S. CAPITAL OF TEXAS HWY STREET 2: BUILDING 3, SUITE 400 CITY: AUSTIN STATE: TX BUSINESS PHONE: 512-885-4957 MAIL ADDRESS: STREET 1: 1250 S. CAPITAL OF TEXAS HWY STREET 2: BUILDING 3, SUITE 400 CITY: AUSTIN STATE: TX D 1 primary_doc.xml X0708 D LIVE 0002141184 Ollin Biosciences, Inc. 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 512-885-4957 DELAWARE None None Corporation true 2022 Jason Ehrlich 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 Executive Officer Director Paul Berns 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 Director Jason Coloma 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 Director Cariad Chester 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 Director Fred Cohen 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 Director Alaa Halawa 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 Director Travis Murdoch 1250 S. CAPITAL OF TEXAS HWY BUILDING 3, SUITE 400 AUSTIN TX TEXAS 78746 Director Biotechnology Decline to Disclose 06b false 2026-05-14 false true false 0 330000000 156249990 173750010 false 32 0 0 0 false Ollin Biosciences, Inc. /s/ Jason Ehrlich Jason Ehrlich Chief Executive Officer 2026-06-24